A systematic review of Helicobacter pylori eradication treatment schedules in children

Alimentary Pharmacology and Therapeutics, Supplement

Volumn 14, Issue 3, 2000, Pages 59-66

  Oderda, G ^a   Rapa, A ^a   Bona, G ^a  

^a UNIVERSITY OF EASTERN PIEDMONT   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; BISMUTH CITRATE; BISMUTH SALICYLATE; CIMETIDINE; CLARITHROMYCIN; FURAZOLIDONE; METRONIDAZOLE; NITROIMIDAZOLE; OMEPRAZOLE; PROTON PUMP INHIBITOR; RANITIDINE; SPIRAMYCIN; STOMACH SECRETION INHIBITOR; TINIDAZOLE;

ANTIBIOTIC THERAPY; CHILD; CONFERENCE PAPER; DRUG EFFECT; DRUG EFFICACY; ERADICATION THERAPY; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HUMAN; PRIORITY JOURNAL;

EID: 0033791058     PISSN: 09530673     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.2000.03102.x     Document Type: Conference Paper

References (57)

1. Helicobacter pylori infection in children. Report of a consensus conference held in Budapest, September 1998
2. The epidemiology of Helicobacter pylori in Peruvian children between 6 and 30 months of age
3. Treatment of Helicobacter pylori infection in infants in rural Bangladesh with oral immunoglobulins from hyperimmune bovine colostrum
4. Clinical symptoms and social factors in a cohort of children spontaneously clearing Helicobacter pylori infection
5. History of antibiotic treatment and prevalence of H. pylori infection among children: Results of a population-based study
6. Helicobacter pylori infection may undergo spontaneous eradication in children: A 2-year follow-up study
7. Low rates of Helicobacter pylori reinfection in children
8. Association of symptoms with Helicobacter pylori infection in children
9. Epidemiology of Helicobacter pylori in Southern China: Identification of early childhood as the critical period for acquisition
10. Age at establishment of Helicobacter pylori infection and gastric carcinoma, gastric ulcer, and duodenal ulcer risk
11. Effectiveness of Helicobacter pylori therapies in a clinical practice setting
12. Campylobacter pyloriassociated gastritis and peptic ulcer disease in children
13. Omeprazole therapy for Helicobacter pylori infection
14. Campylobacter pylori gastritis: Long term results of amoxicillin therapy
15. Treatment and long term follow-up of Helicobacter pylori-associated duodenal ulcer in children
16. Helicobacter pylori and associated duodenal ulcer
17. Dual versus triple therapy of Helicobacter pylori infection: Results of a multicentre trial
18. Amoxicillin plus tinidazole for Campylobacter pylori gastritis in children. Assessment by serum IgG titers, pepsinogen I and gastrin levels
19. Eighteen month follow-up of Helicobacter pylori positive children treated with amoxycillin and tinidazole
20. Helicobacter pylori associated gastritis in Kuwait: Endoscopy based study m symptomatic and asymptomatic children
21. Infections gastriques a Helicobacter pylori chez l'enfant
22. Treatment of Campylobacter pylori-associated antral gastritis in children with bismuth subsalicylate and ampicillin
23. Helicobacter pylori infection and chronic gastritis: Clinical, serological, and histologic correlations in children treated with amoxicillin and colloidal bismuth subcitrate
24. Management and response to treatment of Helicobacter pylori gastritis
25. Amoxicillin plus colloidal bismuth subcitrate: Still an effective treatment against Helicobacter pylori infection in children
26. Effect of Helicobacter pylori eradication on the natural history of duodenal ulcer
27. Helicobacter pylori gastritis in dyspeptic children - A long term follow-up after treatment with colloidal bismuth subcitrate and tinidazole
28. The role of Helicobacter pylori in children with recurrent abdominal pain
29. Long term follow up of duodenal ulcer in children before and after eradication of Helicobacter pylori
30. Helicobacter pylori gastritis and non-ulcer dyspepsia in childhood Efficacy of one-week triple antimicrobial therapy in eradicating the organism
31. One week treatment for Helicobacter pylori infection
32. Safety and efficacy of one-week triple therapy for eradicating Helicobacter pylori in children
33. Helicobacter pylori gastritis in children: Efficacy of 2 weeks of treatment with clarithromycin, amoxicillin and omeprazole
34. Short-term treatment with amoxicillin, clarithromycin and lansoprazole during Helicobacter pylori infection in children
35. Course and diagnostic significance of nodular gastritis in children with Helicobacter pylori infection
36. Spiramycin as an alternative to amoxicillin treatment associated with Iansoprazole for Hellcobacter pylori infection in children
37. Effect of metronidazole resistance on bacterial eradication of Helicobacter pylori in infected children
38. Effective 2-week therapy for Helicobaeter pylori disease in children
39. One-week treatment with omeprazole, clarithromycin, and metronidazole in children with Helicobacter pylori infection
40. Effect of Helicobacter pylori eradication on G-cell and D-cell density in children
41. Treatment of Helicobacter pylori in children: Is a proton pump inhibitor necessary?
42. Evaluation of different treatment schedules in childhood Helicobacter pylori gastritis: A 10 year experience
43. Omeprazole based dual and triple therapy for Helicobacter pylori eradication in children
44. Eradication rates on dual or triple therapies including amoxicillin according to the amoxicillin Mic level in a paediatric population
45. Two week double vs. triple therapy for Helicobacter pylori eradication in Mexican children
46. Helicobacter pylori reinfection after eradication in children
47. Five years follow up of children treated for Helicobacter pylori gastritis
48. Post-treatment reinfection rate of Helicobacter pylori infection in children in Estonia
49. Metronidazole resistance in Helicobacter pylori as a marker for treatment failure in a paediatric population
50. Randomized study comparing two seven days triple therapy for Helicobacter pylori eradication in children
51. Re-infection after Helicobacter pylori eradication in paediatric patients
52. Lansoprazole in the treatment of H. pylori infection in children
53. Clarithromycin resistance in Helicobacter pylori as a marker for treatment failure in a paediatric population
54. Prospective assessment of symptoms and outcome in children with abdominal pain with and without H. pylori infection: Results of a multicenter study
55. Prevalence of clarithromycin-resistant H. pylori-strains in children: Effect on therapy
56. 2 receptor antagonist or omeprazole in the eradication of Helicobacter pylori in children with duodenal ulcer
57. One week triple therapy with omeprazole, clarithromycin, and metronidazole for Helicobacter pylori infection in children and adolescents